Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-23 Option Award | 2024-02-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 1,250 | $0 | 8,391 (Direct) | View |
| 2024-02-23 Tax Withholding | 2024-02-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 567 | $29.06 | 8,391 (Direct) | View |
| 2024-02-23 Disposition | 2024-02-27 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 1,250 | $0 | 8,391 (Direct) | View |
| 2024-02-22 Option Award | 2024-02-26 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 30,750 | $0 | 35,458 (Direct) | View |
| 2024-02-22 Tax Withholding | 2024-02-26 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 303 | $27.94 | 35,458 (Direct) | View |
| 2024-02-22 Disposition | 2024-02-26 5:02 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 750 | $0 | 35,458 (Direct) | View |
| 2023-12-22 Tax Withholding | 2023-12-26 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan Sr. VP, Chief Medical Officer | 204 | $27.66 | 3,243 (Direct) | View |
| 2023-12-22 Exercise | 2023-12-26 5:01 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan Sr. VP, Chief Medical Officer | 600 | $0 | 3,243 (Direct) | View |
| 2023-12-14 Option Award | 2023-12-18 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 600 | $0 | 3,447 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-27 5:03 pm | N/A 2033-02-23 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 25,000 | $0 | 27,497 (Direct) | View |
| 2023-02-22 Option Award | 2023-02-24 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 750 | $0 | 4,747 (Direct) | View |
| 2023-02-22 Disposition | 2023-02-24 5:00 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 750 | $0 | 4,747 (Direct) | View |
| 2023-02-16 Exercise | 2023-02-21 5:01 pm | N/A 2031-04-30 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 1,500 | $0 | 1,500 (Direct) | View |
| 2023-01-12 Option Award | 2023-01-17 5:00 pm | N/A 2031-04-30 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan Sr. VP, Chief Medical Officer | 1,500 | $0 | 1,500 (Direct) | View |
| 2022-02-22 Option Award(A) | 2022-02-25 5:15 pm | N/A 2032-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 28,000 | $0 | 28,000 (Direct) | View |
| 2022-02-22 Option Award | 2022-02-24 9:24 pm | N/A 2032-02-22 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 28,000 | $0 | 28,000 (Direct) | View |
| 2021-02-19 Option Award | 2021-02-23 6:54 pm | N/A 2031-02-19 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 25,000 | $0 | 25,000 (Direct) | View |
Ownership | 2021-01-04 7:59 pm | N/A 2030-02-21 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Rubin Jonathan SVP, Chief Medical Officer | 0 | $0 | 15,000 (Direct) | View |